[HTML][HTML] Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning
SC Juvet, AG Whatcott, AR Bushell, KJ Wood - American Journal of …, 2014 - Elsevier
Owing to the adverse effects of immunosuppression and an inability to prevent chronic
rejection, there is a pressing need for alternative strategies to control alloimmunity. In three …
rejection, there is a pressing need for alternative strategies to control alloimmunity. In three …
Harnessing Regulatory T Cells for Clinical Use in Transplantation: The End of the Beginning
SC Juvet, AG Whatcott, AR Bushell… - American Journal of …, 2014 - infona.pl
Owing to the adverse effects of immunosuppression and an inability to prevent chronic
rejection, there is a pressing need for alternative strategies to control alloimmunity. In three …
rejection, there is a pressing need for alternative strategies to control alloimmunity. In three …
Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning
SC Juvet, AG Whatcott… - American journal of …, 2014 - pubmed.ncbi.nlm.nih.gov
Owing to the adverse effects of immunosuppression and an inability to prevent chronic
rejection, there is a pressing need for alternative strategies to control alloimmunity. In three …
rejection, there is a pressing need for alternative strategies to control alloimmunity. In three …
Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning.
SC Juvet, AG Whatcott, AR Bushell… - American Journal of …, 2014 - europepmc.org
Owing to the adverse effects of immunosuppression and an inability to prevent chronic
rejection, there is a pressing need for alternative strategies to control alloimmunity. In three …
rejection, there is a pressing need for alternative strategies to control alloimmunity. In three …
[引用][C] Harnessing Regulatory T Cells for Clinical Use in Transplantation: The End of the Beginning
SC JUVET, AG WHATCOTT… - American journal of …, 2014 - pascal-francis.inist.fr
Harnessing Regulatory T Cells for Clinical Use in Transplantation: The End of the Beginning
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
Harnessing Regulatory T Cells for Clinical Use in Transplantation: The End of the Beginning
SC Juvet, AG Whatcott, AR Bushell… - American Journal of …, 2014 - Wiley Online Library
Owing to the adverse effects of immunosuppression and an inability to prevent chronic
rejection, there is a pressing need for alternative strategies to control alloimmunity. In three …
rejection, there is a pressing need for alternative strategies to control alloimmunity. In three …
Harnessing regulatory t cells for clinical use in transplantation: The end of the beginning
S Juvet, A Whatcott, A Bushell, K Wood - American Journal of …, 2014 - ora.ox.ac.uk
Owing to the adverse effects of immunosuppression and an inability to prevent chronic
rejection, there is a pressing need for alternative strategies to control alloimmunity. In three …
rejection, there is a pressing need for alternative strategies to control alloimmunity. In three …
[HTML][HTML] Harnessing Regulatory T Cells for Clinical Use in Transplantation: The End of the Beginning
SC Juvet, AG Whatcott, AR Bushell… - American Journal of …, 2014 - amjtransplant.org
Owing to the adverse effects of immunosuppression and an inability to prevent chronic
rejection, there is a pressing need for alternative strategies to control alloimmunity. In three …
rejection, there is a pressing need for alternative strategies to control alloimmunity. In three …
[引用][C] Harnessing Regulatory T Cells for Clinical Use in Transplantation: The End of the Beginning
SC Juvet, AG Whatcott, AR Bushell… - American Journal of …, 2014 - cir.nii.ac.jp
Harnessing Regulatory T Cells for Clinical Use in Transplantation: The End of the
Beginning | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Beginning | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning.
S Juvet, A Whatcott, A Bushell, K Wood - American journal of …, 2014 - ora.ox.ac.uk
Owing to the adverse effects of immunosuppression and an inability to prevent chronic
rejection, there is a pressing need for alternative strategies to control alloimmunity. In three …
rejection, there is a pressing need for alternative strategies to control alloimmunity. In three …